Rockefeller Capital Management L.P. Sells 4,570 Shares of Agilent Technologies, Inc. $A

Rockefeller Capital Management L.P. reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 66,495 shares of the medical research company’s stock after selling 4,570 shares during the period. Rockefeller Capital Management L.P.’s holdings in Agilent Technologies were worth $9,048,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in A. Core Wealth Advisors LLC bought a new position in Agilent Technologies during the 4th quarter worth $26,000. SHP Wealth Management bought a new stake in shares of Agilent Technologies in the fourth quarter valued at about $26,000. Board of the Pension Protection Fund bought a new stake in shares of Agilent Technologies in the fourth quarter valued at about $27,000. Navalign LLC bought a new stake in shares of Agilent Technologies in the fourth quarter valued at about $27,000. Finally, MV Capital Management Inc. acquired a new position in shares of Agilent Technologies in the fourth quarter valued at about $28,000.

Analyst Upgrades and Downgrades

A number of research firms recently commented on A. Barclays raised their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday. UBS Group decreased their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. TD Cowen raised their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Finally, Morgan Stanley cut their price target on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $161.27.

Agilent Technologies Stock Up 3.1%

Shares of NYSE A opened at $135.73 on Friday. The stock has a market capitalization of $38.33 billion, a P/E ratio of 27.25, a PEG ratio of 2.34 and a beta of 1.26. The stock’s fifty day moving average is $122.53 and its 200 day moving average is $126.25. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the prior year, the company posted $1.31 earnings per share. The business’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent completed its acquisition of Biocare Medical, adding immunohistochemistry, in situ hybridization and fluorescence in situ hybridization solutions to its portfolio, which could support longer-term revenue growth and cross-selling opportunities. Article Title
• Positive Sentiment: Barclays raised its price target on Agilent and reiterated an overweight view, signaling Wall Street sees additional upside from current levels. Article Title
• Neutral Sentiment: Piper Sandler initiated coverage with a neutral rating and a $150 price target, which supports valuation but is not an outright bullish call. Article Title
• Neutral Sentiment: Agilent also announced that Shanghai ICRD adopted its software, a modest business win that reinforces demand for its lab and workflow tools. Article Title

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.